Clinical Trial

Implant Placement Depth and Peri-Implant Tissue Outcomes

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary aim of this randomized clinical trial is to evaluate the influence of subcrestal implant placement depth (-2 mm vs -4 mm) on peri-implant marginal bone level changes, including marginal bone loss and bone remodeling. Secondary outcomes include implant success, peri-implant probing depth (PPD), and bleeding on probing (BoP). Partially edentulous patients requiring fixed implant-supported prosthetic rehabilitation with two implants in posterior maxillary or mandibular regions will be included. Implants will be placed subcrestally at either -2 mm or -4 mm from the bone crest, following a submerged healing protocol. Allocation to insertion depth will be randomized. Marginal bone level changes will be assessed using standardized periapical radiographs at second-stage surgery, prosthesis placement, and at 1, 3, 6, and 12 months after functional loading. PPD and BoP will be recorded at the same time points.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-07-14
Trial Details
NCT Number NCT07535528
Lead Sponsor University of Valencia
Conditions Dental Implant Placement, Soft Tissue Management in Subcrestal Dental Implants, Marginal Bone Loss
Enrollment 80 participants
Start Date 2026-05-15
Primary Completion 2026-11-20 (estimated)
Study Completion 2027-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-07-13